General Information of the Compound
| Compound ID |
CP0458110
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-[4-[4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)anilino]piperidin-1-yl]-N-hydroxybenzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C29H35N7O4
|
||||||||||||||||||
| Molecular Weight |
545.644
|
||||||||||||||||||
| Canonical SMILES |
CCCc1nn(C)c2c1nc([nH]c2=O)-c1cc(NC2CCN(CC2)c2ccc(cc2)C(=O)NO)ccc1OCC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H35N7O4/c1-4-6-23-25-26(35(3)33-23)29(38)32-27(31-25)22-17-20(9-12-24(22)40-5-2)30-19-13-15-36(16-14-19)21-10-7-18(8-11-21)28(37)34-39/h7-12,17,19,30,39H,4-6,13-16H2,1-3H3,(H,34,37)(H,31,32,38)
Show/Hide
|
||||||||||||||||||
| InChIKey |
WWAXWNFQIUYRFG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01176, cGMP-specific 3',5'-cyclic phosphodiesterase
Protein ID: PT00991, Histone deacetylase 1
Protein ID: PT00835, Histone deacetylase 2
Protein ID: PT01213, Histone deacetylase 6